Additional file 3: Table S2. of Metronomic cyclophosphamide activation of anti-tumor immunity: tumor model, mouse host, and drug schedule dependence of gene responses and their upstream regulators

Listed are all CPA-induced upstream regulators (UPRs) as predicted by IPA for CPA-treated GL261(B6) (Table S2A), LLC (Table S2B), B16F10 (Table S2C), GL261(scid) (Table S2D; CPA/6d treatment), and GL261(scid) (Table S2E; CPA/9d treatment) tumors, respectively. (XLSX 960 kb)

本列表依次列出了通过Ingenuity通路分析（Ingenuity Pathway Analysis，IPA）预测得到的、由CPA（环磷酰胺，Cyclophosphamide）诱导的上游调控因子（upstream regulators, UPRs），这些调控因子分别来自经CPA处理的以下肿瘤模型：GL261(B6)（对应表S2A）、LLC（对应表S2B）、B16F10（对应表S2C）、GL261(scid)（CPA处理6天，对应表S2D）以及GL261(scid)（CPA处理9天，对应表S2E）。本数据集文件为XLSX格式，大小为960 kb。